Diphosphonate bone scans in patients with polyarthralgias

Area of Science:

• Nuclear medicine
• Rheumatology
• Diagnostic imaging

Background:

• Early detection of inflammatory arthropathy is challenging with conventional methods.
• Standard radiography and laboratory tests are often inconclusive in early stages.
• Persistent polyarthralgias require sensitive diagnostic tools.

Purpose of the Study:

• To evaluate the utility of technetium Tc 99m medronate bone scintigraphy in diagnosing inflammatory arthropathy.
• To assess the correlation between scan findings and clinical presentation.
• To determine the impact of scintigraphy on patient management and therapeutic outcomes.

Main Methods:

• Technetium Tc 99m medronate bone scintigraphy was performed on 16 patients with persistent polyarthralgias.
• Patients had no clinical synovitis, normal radiographs, and nondiagnostic laboratory results.
• Scan results were correlated with clinical symptoms and subsequent treatment.

Main Results:

• Abnormal scintigraphy findings were observed in 11 out of 16 patients (69%).
• Scan abnormalities localized to symptomatic joints in all 11 patients with positive scans.
• Patients with abnormal scans showed significant improvement with targeted therapies.
• Patients with normal scans received symptomatic treatment with favorable outcomes or were diagnosed with other conditions.

Conclusions:

• Technetium Tc 99m medronate scintigraphy is a valuable tool for detecting early inflammatory arthropathy when other tests are negative.
• Abnormal bone turnover detected by scintigraphy can indicate underlying inflammatory processes.
• This imaging modality aids in guiding therapeutic decisions and improving patient management for undiagnosed polyarthralgias.